Sign in

CIK 0001728328

  • Emerging growth company

Mentari Therapeutics, Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
981428279
Phone
+1 781-887-5080
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
InMed Pharmaceuticals Inc.
Open-market buys, last 90 days
$238,371
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$238K 10% owner 7 filings
Date Insider Transaction Shares Price Value Owned after
2024-12-20 HULL ANDREW Director Grant or award · Employee Stock Option (Right to Buy) +550 977
2024-07-31 MANCINI ALEXANDRA DIANE JANET Consultant Sale −240 $0.18 $42 0
2024-05-27 WOUDENBERG MICHAEL Chief Operating Officer Other disposition · Employee Stock Option (Expiration) −394 75,100
2024-05-27 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −545 52,000
2024-05-27 ADAMS ERIC A President & CEO Other disposition · Employee Stock Option (Expiration) −1,139 161,000
2024-05-27 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −485 52,000
2024-03-04 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −309 52,545
2024-02-21 HULL ANDREW Director Purchase +37,500 $0.39 $15K 38,258
2024-02-20 ADAMS ERIC A President & CEO Purchase +41,600 $0.36 $15K 43,959
2024-01-21 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −121 52,485
2024-01-14 HULL ANDREW Director Other disposition · Employee Stock Option (Expiration) −42 8,542
2023-12-23 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +40,000 48,000
2023-12-23 Lemerond Nicole Director Grant or award · Employee Stock Option (Right to Buy) +7,100 8,500
2023-12-23 WOUDENBERG MICHAEL Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +65,000 75,494
2023-12-23 Tegge Jonathan Interim CFO Grant or award · Employee Stock Option (Right to Buy) +30,000 31,400
2023-12-23 Grove Janet P Director Grant or award · Employee Stock Option (Right to Buy) +7,100 8,500
2023-12-23 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Grant or award · Employee Stock Option (Right to Buy) +45,000 52,854
2023-12-23 ADAMS ERIC A President & CEO Grant or award · Employee Stock Option (Right to Buy) +136,000 162,139
2023-12-23 Baldasare Bryan T Director Grant or award · Employee Stock Option (Right to Buy) +7,100 8,500
2023-12-23 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Grant or award · Employee Stock Option (Right to Buy) +45,000 52,606

Page 5 of 9 · 173 trades